Table 1 Comparison of baseline anthropometric, laboratory and echocardiographic parameters of study participants
Variables | MACE | Total (n = 276) | P value | |
|---|---|---|---|---|
No (n = 212) | Yes (n = 64) | |||
Age (years) | 63.2 ± 10.9 | 68.0 ± 11.1 | 64.3 ± 11.4 | 0.002* |
Female gender | 47 (22.2) | 24 (37.5) | 71 (25.7) | 0.014† |
BMI (kg/m2) | 27.8 (25.8–30.9) | 26.6 (24.4–29.8) | 27.8 (25.4–30.7) | 0.026‡ |
NSTE-ACS subtype | 0.733† | |||
NSTEMI | 175 (82.5) | 54 (84.4) | 229 (83.0) | |
UA | 37 (17.5) | 10 (15.6) | 47 (17.0) | |
Arterial hypertension | 131 (61.8) | 46 (71.9) | 177 (64.1) | 0.140† |
Diabetes mellitus | 60 (28.3) | 23 (35.9) | 83 (30.1) | 0.110† |
Hypercholesterolemia | 106 (50.0) | 32 (50.0) | 138 (50.0) | 0.999† |
Family history of CVD | 76 (35.8) | 25 (39.1) | 101 (36.6) | 0.640† |
Active smoking | 62 (29.2) | 14 (21.9) | 76 (27.5) | 0.260† |
Atrial fibrillation | 15 (7.1) | 11 (17.2) | 26 (9.4) | 0.015† |
Prior CAD | 8 (3.8) | 4 (6.3) | 12 (4.3) | 0.395† |
Prior MI | 19 (9.0) | 11 (17.2) | 30 (10.9) | 0.066† |
Prior PCI | 17 (8.0) | 6 (9.4) | 23 (8.3) | 0.731† |
PAD | 20 (9.5) | 9 (14.1) | 29 (10.5) | 0.432† |
COPD | 26 (12.2) | 7 (10.9) | 33 (12.0) | 0.920† |
Killip class > 1 | 20 (9.0) | 8 (12.5) | 28 (9.8) | 0.692† |
Hgb (g/L) | 143.0 (134.0–153.0) | 137.0 (123.3–149.0) | 141.2 (133.0–152.0) | 0.010‡ |
Glucose (mmol/L) | 7.1 (6.0–9.9) | 7.4 (6.1–9.6) | 7.1 (6.0–9.7) | 0.672‡ |
CRP (mmol/L) | 5.1 (2.0–10.5) | 8.6 (1.5–29.3) | 5.7 (1.7–12.9) | 0.128‡ |
eGFR (ml/min) | 91.8 ± 27.1 | 81.9 ± 28.3 | 89.5 ± 27.7 | 0.017* |
LVEF (%) | 59.0 (55.0–65.0) | 55.0 (51.3–62.0) | 58.0 (55.0–65.0) | 0.046‡ |
Follow-up (months) | 36.1 (29.5–43.8) | 32.6 (26.5–43.5) | 35.1 (29.3–44.0) | 0.089‡ |